BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 724482)

  • 1. [Chemotherapy of ovarian cancers, stage III].
    Amiel JL
    Nouv Presse Med; 1978 Oct; 7(35):3150-1. PubMed ID: 724482
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for ovarian cancer.
    Adlan A; Sen DK; Sivanesaratnam V
    Med J Malaysia; 1981 Sep; 36(3):159-65. PubMed ID: 7329372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of stage III and IV ovarian carcinoma].
    Neijt JP; Barents JW; Vendrik CP; van Lindert AC; Struyvenberg A; Pinedo HM
    Ned Tijdschr Geneeskd; 1980 Sep; 124(38):1601-5. PubMed ID: 7412949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of 2 combined chemotherapy protocols in the treatment of stage III-IV ovarian cancer patients].
    Marenich AF; Perevodchikova NI; Grigorova TM; Pashkiavichus RI
    Vestn Akad Med Nauk SSSR; 1980; (5):28-32. PubMed ID: 7395336
    [No Abstract]   [Full Text] [Related]  

  • 5. [Second laparotomy in cancers of the ovary treated with chemotherapy. 17 cases (author's transl)].
    Amiel JL; Michel G; Droz JP; Tursz T; Ben Ayed F
    Nouv Presse Med; 1980 Dec; 9(47):3605-8. PubMed ID: 6937069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israƫl L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
    Barlow JJ; Piver MS
    Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer: current management.
    Tyler H; Kardinal CG
    Mo Med; 1981 Jan; 78(1):13-6. PubMed ID: 7219403
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J; Du Bois A
    MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW; Orr P; Kern DH
    Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
    Wada Y; Suzuki M; Shinagawa S; Saito Y; Nishiya I; Maki M; Yajima A; Hiroi M; Sato A
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New developments in the chemotherapy of ovarian cancer (author's transl)].
    Brunner KW; Goldhirsch A; Joss R
    Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status and future developments in chemotherapy of advanced epithelial ovarian cancers (author's transl)].
    Szepesi T
    Wien Klin Wochenschr; 1981 Apr; 93(8):251-5. PubMed ID: 6266166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of chemotherapy in the ovarian malignancy treated with reduction surgery (author's transl)].
    Terashima Y; Yasuda M; Tajima T; Ota Y; Okawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Sep; 33(9):1355-70. PubMed ID: 7276656
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of advanced ovarian carcinoma.
    N Engl J Med; 1979 Mar; 300(12):676-7. PubMed ID: 763291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.